Persistent Asset Partners LTD Reviva Pharmaceuticals Holdings, Inc. Transaction History
Persistent Asset Partners LTD
- $119 Billion
- Q1 2025
A detailed history of Persistent Asset Partners LTD transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 160,310 shares of RVPH stock, worth $112,217. This represents 0.13% of its overall portfolio holdings.
Number of Shares
160,310
Previous 161,170
0.53%
Holding current value
$112,217
Previous $305 Million
49.8%
% of portfolio
0.13%
Previous 0.25%
Shares
2 transactions
Others Institutions Holding RVPH
# of Institutions
56Shares Held
7.42MCall Options Held
938KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA1.8MShares$1.26 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$1.07 Million0.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$455,5060.16% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$357,2300.03% of portfolio
-
Geode Capital Management, LLC Boston, MA419KShares$293,3970.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $14.3M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...